News

Before his heart transplant, Robert Johnson had a hard time even cutting his grass. Now, after receiving a heart transplant at Saint Luke's Mid America Heart Institute, he is back to enjoying physical activities, like golf.

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and type 2 diabetes had significant improvement in symptoms and physical limitations when taking semaglutide.

Saint Luke’s Mid America Heart Institute today announced results from the STEP HFpEF DM trial.

Dr. James O'Keefe weighs in on a new study that found eating more than a dozen fortified eggs a week did not negatively affect cholesterol levels.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

As a winner of the Press Ganey HX Guardian of Excellence Award®, Hedrick is in the top 5% of healthcare providers nationwide in delivering rehabilitation services in the last year.

New study led by Saint Luke’s Mid America Heart Institute cardiologists reveals lower risk of all-cause and cause-specific mortality associated with higher docosahexaenoic acid (DHA) blood levels

Amanda Davis joined KMBC's Heart of the Matter to talk about healing and how to best talk to children one month after the Chiefs rally shooting.